FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160361307> ?p ?o ?g. }

• W2160361307 endingPage "25807" @default.
• W2160361307 startingPage "25802" @default.
• W2160361307 abstract "Serum- and glucocorticoid-regulated kinase (SGK) is a serine kinase that has a catalytic domain homologous to that of Akt, but lacks the pleckstrin homology domain present in Akt. Akt reportedly plays a key role in various cellular actions, including glucose transport, glycogen synthesis, DNA synthesis, anti-apoptotic activity, and cell proliferation. In this study, we attempted to reveal the different roles of SGK and Akt by overexpressing active mutants of Akt and SGK. We found that adenovirus-mediated overexpression of myristoylated (myr-) forms of Akt resulted in high glucose transport activity in 3T3-L1 adipocytes, phosphorylated glycogen synthase kinase-3 (GSK3) and enhanced glycogen synthase activity in hepatocytes, and the promotion of DNA synthesis in interleukin-3-dependent 32D cells. In addition, stable transfection of myr-Akt in NIH3T3 cells induced an oncogenic transformation in soft agar assays. The active mutant of SGK (D-SGK, substitution of Ser422 with Asp) and myr-SGK were shown to phosphorylate GSK3 and to enhance glycogen synthase activity in hepatocytes in a manner very similar to that observed for myr-Akt. However, despite the comparable degree of GSK3 phosphorylation between myr-Akt and d-SGK or myr-SGK, d-SGK and myr-SGK failed to enhance glucose transport activity in 3T3-L1 cells, DNA synthesis in 32D cells, and oncogenic transformation in NIH3T3 cells. Therefore, the different roles of SGK and Akt cannot be attributed to ability or inability to translocate to the membrane thorough the pleckstrin homology domain, but rather must be attributable to differences in the relatively narrow substrate specificities of these kinases. In addition, our observations strongly suggest that phosphorylation of GSK3 is either not involved in or not sufficient for GLUT4 translocation, DNA synthesis, or oncogenic transformation. Thus, the identification of substrates selectively phosphorylated by Akt, but by not SGK, may provide clues to clarifying the pathway leading from Akt activation to these cellular activities. Serum- and glucocorticoid-regulated kinase (SGK) is a serine kinase that has a catalytic domain homologous to that of Akt, but lacks the pleckstrin homology domain present in Akt. Akt reportedly plays a key role in various cellular actions, including glucose transport, glycogen synthesis, DNA synthesis, anti-apoptotic activity, and cell proliferation. In this study, we attempted to reveal the different roles of SGK and Akt by overexpressing active mutants of Akt and SGK. We found that adenovirus-mediated overexpression of myristoylated (myr-) forms of Akt resulted in high glucose transport activity in 3T3-L1 adipocytes, phosphorylated glycogen synthase kinase-3 (GSK3) and enhanced glycogen synthase activity in hepatocytes, and the promotion of DNA synthesis in interleukin-3-dependent 32D cells. In addition, stable transfection of myr-Akt in NIH3T3 cells induced an oncogenic transformation in soft agar assays. The active mutant of SGK (D-SGK, substitution of Ser422 with Asp) and myr-SGK were shown to phosphorylate GSK3 and to enhance glycogen synthase activity in hepatocytes in a manner very similar to that observed for myr-Akt. However, despite the comparable degree of GSK3 phosphorylation between myr-Akt and d-SGK or myr-SGK, d-SGK and myr-SGK failed to enhance glucose transport activity in 3T3-L1 cells, DNA synthesis in 32D cells, and oncogenic transformation in NIH3T3 cells. Therefore, the different roles of SGK and Akt cannot be attributed to ability or inability to translocate to the membrane thorough the pleckstrin homology domain, but rather must be attributable to differences in the relatively narrow substrate specificities of these kinases. In addition, our observations strongly suggest that phosphorylation of GSK3 is either not involved in or not sufficient for GLUT4 translocation, DNA synthesis, or oncogenic transformation. Thus, the identification of substrates selectively phosphorylated by Akt, but by not SGK, may provide clues to clarifying the pathway leading from Akt activation to these cellular activities. PI 1The abbreviations used are: PI, phosphatidylinositol; SGK, serum- and glucocorticoid-regulated kinase; GLUT4, glucose transporter-4; GSK3, glycogen synthase kinase-3; PDK, phosphoinositide-dependent kinase; PH, pleckstrin homology; myr-, myristoylated; DMEM, Dulbecco's modified Eagle's medium; FCS, fetal calf serum; IL-3, interleukin-3; BrdUrd, bromodeoxyuridine; WT, wild-type. 3-kinase has been implicated in the regulation of numerous cellular processes (1Kahn C.R. Folli F. Horm. Res. (Basel). 1993; 39: 93-101Crossref PubMed Scopus (28) Google Scholar, 2Egawa K. Sharma P.M. Nakashima N. Huang Y. Huver E. Boss G.R. Olefsky J.M. J. Biol. Chem. 1999; 274: 14306-14314Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar, 3Cantley L.C. Science. 2002; 296: 1655-1657Crossref PubMed Scopus (4657) Google Scholar). The lipid product of PI 3-kinase reportedly activates several AGC kinases, including Akt, atypical protein kinases C, p70 S6 kinase, and SGK (3Cantley L.C. Science. 2002; 296: 1655-1657Crossref PubMed Scopus (4657) Google Scholar, 45Czech M.P. Corvera S. J. Biol. Chem. 1999; 274: 1865-1868Abstract Full Text Full Text PDF PubMed Scopus (450) Google Scholar). Among these AGC kinases, Akt was found to mediate various insulin- and growth factor-induced cellular responses such as stimulation of GLUT4 translocation to the plasma membrane (10Kohn A.D. Summers S.A. Birnbaum M.J. Roth R.A. J. Biol. Chem. 1996; 271: 31372-31378Abstract Full Text Full Text PDF PubMed Scopus (1093) Google Scholar, 11Hajduch E. Alessi D.R. Hemmings B.A. Hundal H.S. Diabetes. 1998; 47: 1006-1013Crossref PubMed Scopus (296) Google Scholar, 46Wang Q. Somwar R. Bilan P.J. Liu Z. Jin J. Woodgett J.R. Klip A. Mol. Cell. Biol. 1999; 19: 4008-4018Crossref PubMed Scopus (502) Google Scholar, 47Foster L.J. Li D. Randhawa V.K. Klip A. J. Biol. Chem. 2001; 276: 44212-44221Abstract Full Text Full Text PDF PubMed Scopus (90) Google Scholar), inhibition of GSK3 (22Cross D.A. Alessi D.R. Cohen P. Andjelkovich M. Hemmings B.A. Nature. 1995; 378: 785-789Crossref PubMed Scopus (4376) Google Scholar), and promotion of cell survival by inhibiting apoptosis (4Vivanco I. Sawyers C.L. Nat. Rev. Cancer. 2002; 2: 489-501Crossref PubMed Scopus (5144) Google Scholar, 5Blume-Jensen P. Hunter T. Nature. 2001; 411: 355-365Crossref PubMed Scopus (3144) Google Scholar, 6Vanhaesebroeck B. Alessi D.R. Biochem. J. 2000; 346: 561-576Crossref PubMed Scopus (1399) Google Scholar, 7Corvera S. Czech M.P. Trends Cell Biol. 1998; 8: 442-446Abstract Full Text Full Text PDF PubMed Scopus (186) Google Scholar, 8Hemmings B.A. Science. 1997; 275: 628-630Crossref PubMed Scopus (437) Google Scholar). In addition, as shown by the v-Akt data, constitutively activated Akt has transforming activity (9Staal S.P. Proc. Natl. Acad. Sci. U. S. A. 1987; 84: 5034-5037Crossref PubMed Scopus (646) Google Scholar). These cellular activities have been shown to be induced by overexpression of constitutively activated Akt or its membrane-targeted mutant. For example, glucose uptake is reportedly increased in both constitutively activated Akt-overexpressing 3T3-L1 adipocytes and L6 myotubes (10Kohn A.D. Summers S.A. Birnbaum M.J. Roth R.A. J. Biol. Chem. 1996; 271: 31372-31378Abstract Full Text Full Text PDF PubMed Scopus (1093) Google Scholar, 11Hajduch E. Alessi D.R. Hemmings B.A. Hundal H.S. Diabetes. 1998; 47: 1006-1013Crossref PubMed Scopus (296) Google Scholar), whereas Akt2-deficient mice show impaired glucose tolerance due to decreased insulin-induced glucose uptake in skeletal muscle and increased hepatic glucose production (12Cho H. Mu J. Kim J.K. Thorvaldsen J.L. Chu Q. Crenshaw III, E.B. Kaestner K.H. Bartolomei M.S. Shulman G.I. Birnbaum M.J. Science. 2001; 292: 1728-1731Crossref PubMed Scopus (1547) Google Scholar). On the other hand, SGK, the expression level of which is increased by glucocorticoid and serum stimulation in cultured cells (13Webster M.K. Goya L. Ge Y. Maiyar A.C. Firestone G.L. Mol. Cell. Biol. 1993; 13: 2031-2040Crossref PubMed Scopus (497) Google Scholar, 48Mizuno H. Nishida E. Genes Cells. 2001; 6: 261-268Crossref PubMed Scopus (66) Google Scholar), is the one member of the AGC kinase family with a highly conserved kinase domain compared with that of Akt (54% identical amino acids) (14Kobayashi T. Cohen P. Biochem. J. 1999; 339: 319-328Crossref PubMed Scopus (529) Google Scholar, 15Kobayashi T. Deak M. Morrice N. Cohen P. Biochem. J. 1999; 344 (Pt 1): 189-197Crossref PubMed Scopus (335) Google Scholar). Indeed, the substrate specificity of the kinase domain of SGK has been reported to be similar to that of Akt (16Casamayor A. Torrance P.D. Kobayashi T. Thorner J. Alessi D.R. Curr. Biol. 1999; 9: 186-197Abstract Full Text Full Text PDF PubMed Scopus (204) Google Scholar). Furthermore, it was also reported that the PI 3-kinase pathway activates SGK through PDK1/2, i.e. in the same manner as for Akt (17Park J. Leong M.L. Buse P. Maiyar A.C. Firestone G.L. Hemmings B.A. EMBO J. 1999; 18: 3024-3033Crossref PubMed Scopus (482) Google Scholar, 49Virbasius J.V. Song X. Pomerleau D.P. Zhan Y. Zhou G.W. Czech M.P. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 12908-12913Crossref PubMed Scopus (76) Google Scholar). However, the most apparent difference in the structures of SGK and Akt is that SGK lacks the PH domain that Akt has. Thus, SGK is considered to not be able to translocate to the membrane like Akt in response to growth factor stimulation. In fact, it was reported that insulin stimulation induces the translocation of Akt to the membrane fraction, but that this does not occur with mutant Akt lacking the PH domain or with SGK (18Sable C.L. Filippa N. Filloux C. Hemmings B.A. Van Obberghen E. J. Biol. Chem. 1998; 273: 29600-29606Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar). Although recent studies revealed a possible role of SGK in aldosterone-induced apical translocation of the epithelial sodium channel in distal nephrons (19Bhargava A. Fullerton M.J. Myles K. Purdy T.M. Funder J.W. Pearce D. Cole T.J. Endocrinology. 2001; 142: 1587-1594Crossref PubMed Scopus (125) Google Scholar, 20Chen S.Y. Bhargava A. Mastroberardino L. Meijer O.C. Wang J. Buse P. Firestone G.L. Verrey F. Pearce D. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 2514-2519Crossref PubMed Scopus (639) Google Scholar, 21Verrey F. Am. J. Physiol. 1999; 277: F319-F327Crossref PubMed Google Scholar), it seems that our understanding of the roles of SGK remains limited. In this study, we investigated whether SGK induces the cellular functions known to be induced by activated Akt. Akt activation reportedly plays a key role in glucose metabolism, including increased glycogen synthase and GLUT4 translocation to the plasma membrane, as well as in inhibition of apoptosis and promotion of cell growth. The induction of these cellular functions by Akt has been well demonstrated, and they are also induced by overexpressing myr-Akt (10Kohn A.D. Summers S.A. Birnbaum M.J. Roth R.A. J. Biol. Chem. 1996; 271: 31372-31378Abstract Full Text Full Text PDF PubMed Scopus (1093) Google Scholar, 11Hajduch E. Alessi D.R. Hemmings B.A. Hundal H.S. Diabetes. 1998; 47: 1006-1013Crossref PubMed Scopus (296) Google Scholar, 22Cross D.A. Alessi D.R. Cohen P. Andjelkovich M. Hemmings B.A. Nature. 1995; 378: 785-789Crossref PubMed Scopus (4376) Google Scholar). Thus, we constructed the active mutant of SGK and myr-SGK and investigated whether these SGK mutants can exert the same actions as myr-Akt. This is the first report clearly demonstrating the different roles of Akt and SGK. In addition, interestingly, these differences are attributable not to the presence or absence of the PH domain responsible for membrane targeting, but very possibly to differences in the substrate specificities of the kinase domains of SGK and Akt. Antibodies—Anti-Myc tag (clone 9E10), anti-phospho-Ser21 GSK3α, and anti-SGK antibodies were purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). Anti-Akt and anti-phospho-Ser473 Akt antibodies were purchased from Cell Signaling Technology (Beverly, MA). Cell Culture—Hepatocytes were isolated from fasted rats by collagenase perfusion as described previously (23Ogihara T. Asano T. Ando K. Chiba Y. Sakoda H. Anai M. Shojima N. Ono H. Onishi Y. Fujishiro M. Katagiri H. Fukushima Y. Kikuchi M. Noguchi N. Aburatani H. Komuro I. Fujita T. Hypertension. 2002; 40: 872-879Crossref PubMed Scopus (227) Google Scholar) and plated in collagen-coated 25-cm2 flasks at a density of 1.0 × 105 cells/cm2 in DMEM supplemented with 10% FCS, 0.5 μg/ml insulin, 1 μm dexamethasone, and 10 ng/ml epidermal growth factor. After a 6-h attachment period, hepatocytes were transfected using adenoviral gene transfer. 3T3-L1 fibroblasts were maintained in DMEM supplemented with 10% donor calf serum (Invitrogen) under a 10% CO2 atmosphere at 37 °C. 2 days after the fibroblasts reached confluence, differentiation was induced by incubating the cells for 48 h in DMEM supplemented with 10% fetal bovine serum, 0.5 mmol/liter 3-isobutyl-1-methylxanthine, and 4 mg/ml dexamethasone. Thereafter, the cells were maintained in DMEM supplemented with 10% fetal bovine serum for an additional 4–10 days; once >90% of the cells expressed the adipocyte phenotype, the cells were used for experimentation. 32D cells were maintained in RPMI 1640 medium with 10% FCS and 0.25 ng/ml murine IL-3 (24Kurokawa M. Mitani K. Imai Y. Ogawa S. Yazaki Y. Hirai H. Blood. 1998; 92: 4003-4012Crossref PubMed Google Scholar). NIH3T3 cells were maintained in DMEM with 10% FCS. Each cDNA was transfected into NIH3T3 cells with an expression vector (pCAGGs), and the permanently expressing clones were selected in DMEM containing 500 mg/liter Geneticin. Construction of SGK Mutants and myr-Akt—3A-SGK, a dominant-negative form of SGK, was constructed by substituting lysine 127, threonine 256, and serine 422 with alanines. d-SGK was constructed by substituting serine 422 with aspartic acid. myr-SGK contains an src myristoylation signal sequence at the N terminus. MAA-Akt, a dominant-negative form of Akt, was constructed by substituting lysine 179, threonine 308, and serine 473 with alanines. myr-Akt, which contains an src myristoylation signal sequence, was described previously (25Sakoda H. Ogihara T. Anai M. Funaki M. Inukai K. Katagiri H. Fukushima Y. Onishi Y. Ono H. Fujishiro M. Kikuchi M. Oka Y. Asano T. Diabetes. 2000; 49: 1700-1708Crossref PubMed Scopus (192) Google Scholar). All the constructs were designed to contain a Myc tag at the C terminus, and their structures are shown in Fig. 1. Recombinant adenoviruses were generated, purified, and concentrated using cesium chloride ultracentrifugation as reported previously (26Katagiri H. Asano T. Ishihara H. Inukai K. Shibasaki Y. Kikuchi M. Yazaki Y. Oka Y. J. Biol. Chem. 1996; 271: 16987-16990Abstract Full Text Full Text PDF PubMed Scopus (152) Google Scholar, 27Sakoda H. Ogihara T. Anai M. Fujishiro M. Ono H. Onishi Y. Katagiri H. Abe M. Fukushima Y. Shojima N. Inukai K. Kikuchi M. Oka Y. Asano T. Am. J. Physiol. 2002; 282: E1239-E1244Crossref PubMed Scopus (79) Google Scholar). Equal amounts of Akt and SGK were overexpressed throughout all of the experiments. Gene Transfer into Each Cell Type—For gene transfer into hepatocytes, cells were incubated for 1 h at 37 °C in DMEM containing 1.0 × 108 plaque-forming units/ml recombinant adenovirus, after which the virus-containing medium was replaced with normal growth medium. Glycogen synthase assays were performed 36 h later. For gene transfer into 3T3-L1 adipocytes, cells were incubated for 6 h at 37 °C in DMEM containing recombinant adenovirus. Experiments were performed 2 days later. 32D cells were incubated for 6 h at 37 °C in RPMI 1640 medium containing recombinant adenovirus. 24 h after adenoviral gene transfer, the cells were IL-3-starved for an additional 24 h, and then DNA synthesis assays were performed. In 3T3-L1 adipocytes and 32D cells, all recombinant adenoviruses were used at a concentration of 3.0 × 109 plaque-forming units/ml. Under these conditions, none of the cells infected with LacZ exhibited significant differences in glycogen synthesis or glucose transport activity compared with non-infected cells, and 95∼100% of the cells were infected as judged by blue coloration after 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside (X-gal) incubation 36∼48 h after infection. Immunoprecipitation and Immunoblotting—The cells were collected and boiled in Laemmli sample buffer containing 100 mmol/liter dithiothreitol. SDS-PAGE and immunoblotting were performed as described previously (27Sakoda H. Ogihara T. Anai M. Fujishiro M. Ono H. Onishi Y. Katagiri H. Abe M. Fukushima Y. Shojima N. Inukai K. Kikuchi M. Oka Y. Asano T. Am. J. Physiol. 2002; 282: E1239-E1244Crossref PubMed Scopus (79) Google Scholar) using each antibody as a probe. Glycogen Synthase Assay—After 3 h of serum starvation, cells in 25-cm2 flasks were stimulated with or without 100 nm insulin for 30 min. The cells were homogenized in homogenizing buffer containing 50 mm Tris, 10 mm EDTA, and 100 mm NaF. 50 μg of liver samples were then assayed in glycogen synthase buffer containing 8.9 mm UDP-[6-3H]glucose (1 Ci/mmol) in the absence or presence of 10 mm Glu-6-P for 20 min at 30 °C. UDP-[6-3H]glucose incorporation into glycogen was measured by liquid scintillation counting. Glucose Transport Assay—3T3-L1 adipocytes in 24-well culture dishes were serum-starved for 3 h in DMEM containing 0.2% bovine serum albumin. They were next incubated for 45 min in glucose-free Krebs-Ringer phosphate buffer (137 mm NaCl, 4.7 mm KCl, 10 mm sodium phosphate (pH 7.4), 0.5 mm MgCl2, and 1 mm CaCl2) and then incubated with or without 100 nm insulin for 15 min. Basal and stimulated uptakes of 2-deoxy-d-[3H]glucose were then measured as described previously (28Sakoda H. Ogihara T. Anai M. Funaki M. Inukai K. Katagiri H. Fukushima Y. Onishi Y. Ono H. Yazaki Y. Kikuchi M. Oka Y. Asano T. Diabetes. 1999; 48: 1365-1371Crossref PubMed Scopus (45) Google Scholar). DNA Synthesis Assay—32D cells were maintained in RPMI 1640 medium supplemented with 10% FCS and 0.25 ng/ml IL-3. After incubation in IL-3-free RPMI 1640 medium for 24 h, the cells were incubated with BrdUrd labeling solution for 6 h. BrdUrd incorporation was measured using the BrdUrd labeling and detection kit III (Roche Applied Science) (44Glowacki J. Mizuno S. Greenberger J.S. Cell Transplant. 1998; 7: 319-326Crossref PubMed Scopus (128) Google Scholar). Soft Agar Assays—For the soft agar assay, cells of each transfected derivative were trypsinized, suspended in DMEM containing 0.3% agar and 20% FCS, and plated onto a bottom layer containing 0.6% agar. Cells were plated at a density of 2 × 104 cells/3.5-cm dish, and colonies >0.5 mm in diameter were counted after 14 days (29Kurokawa M. Tanaka T. Tanaka K. Hirano N. Ogawa S. Mitani K. Yazaki Y. Hirai H. J. Biol. Chem. 1996; 271: 16870-16876Abstract Full Text Full Text PDF PubMed Scopus (39) Google Scholar). All procedures were performed in three independent experiments, and similar results were obtained. Statistical Analysis—Results are expressed as means ± S.E. Comparisons were made using unpaired Student's t test. Values of p <0.05 were considered statistically significant. Effect of SGK or Akt Overexpression on Glucose Transport— WT-Akt, MAA-Akt, myr-Akt, WT-SGK, 3A-SGK, and myr-SGK were overexpressed in 3T3-L1 adipocytes. Immunoblotting with anti-Myc tag antibody revealed the expression levels of Akt and SGK and their mutants to be comparable (Fig. 2A, first panel). In addition, the expression levels of WT-Akt, MAA-Akt, and myr-Akt were approximately five times those of endogenously expressed Akt judging from the immunoblotting results using anti-Akt antibody (Fig. 2A, second panel), and basal phosphorylation was observed in myr-Akt (third panel). On the other hand, endogenously expressed SGK was not detectable in 3T3-L1 adipocytes, whereas overexpressed WT-SGK, 3A-SGK, and myr-SGK were detected by immunoblotting (Fig. 2A, fourth panel). Increased phosphorylation of GSK3 was observed in 3T3-L1 adipocytes overexpressing myr-Akt, d-SGK, and myr-SGK, whereas overexpression of wild-type and dominant-negative mutants of Akt and SGK did not increase GSK3 phosphorylation (Fig. 2A, fifth panel). Finally, interestingly, although 2-deoxy-d-[3H]glucose uptake into 3T3-L1 adipocytes was increased 8-fold by overexpression of myr-Akt compared with that of LacZ, d-SGK or myr-SGK overexpression had essentially no effect on 2-deoxy-d-[3H]glucose uptake (Fig. 2B). Effect of SGK or Akt Overexpression on Phosphorylation of GSK3 and Glycogen Synthesis—To confirm that phosphorylated GSK3 elevates glycogen synthesis irrespective of whether Akt or SGK phosphorylates GSK3, active mutants of Akt (myr-Akt) and SGK (d-SGK and myr-SGK) were overexpressed in primary cultured rat hepatocytes. The expression levels of myr-Akt, D-SGK, and myr-SGK were comparable, as shown by immunoblotting using anti-Myc tag antibody (Fig. 3A). Similar to the observations in 3T3-L1 adipocytes, overexpression of these active mutants of Akt and SGK induced an apparent increase in phosphorylation of GSK3, as did insulin stimulation (Fig. 3B). As shown in Fig. 3C, glycogen synthase activity was shown to be significantly increased (∼1.5-fold) either by 30 min of stimulation with insulin or by overexpression of myr-Akt, d-SGK, or myr-SGK compared with the control. Thus, it is clear that phosphorylation of GSK3 results in the elevation of glycogen synthesis irrespective of phosphorylation by either Akt or SGK. Effect of SGK or Akt Overexpression on DNA Synthesis—WT-Akt, MAA-Akt, myr-Akt, WT-SGK, 3A-SGK, and myr-SGK were overexpressed in 32D cells by adenoviral transfer so that their expression levels were similar (Fig. 4A), and the effects on DNA synthesis were examined by measuring BrdUrd incorporation. Because 32D is an IL-3-dependent cell line, removal of IL-3 from the medium reportedly induces apoptosis, which can be shown to be the result of suppressed DNA synthesis. Overexpression of myr-Akt, D-SGK, and myr-SGK induced GSK3 phosphorylation to a similar degree, whereas that of WT-Akt, MAA-Akt, WT-SGK, and 3A-SGK did not (Fig. 4B). However, interestingly, overexpression of only myr-Akt significantly enhanced the protection from apoptosis achieved by lack of IL-3 (Fig. 4C). On the other hand, overexpression of d-SGK or myr-SGK had no inhibitory effect on apoptosis, despite phosphorylation of GSK3. myr-Akt Overexpression Alone Can Transform NIH3T3 Cells—Finally, we analyzed the transforming ability of Akt and SGK by evaluating the capacity for anchorage-independent growth. NIH3T3 cells stably transfected with either Akt or SGK constructs were seeded in DMEM containing 0.3% agar and 20% FCS, and colony formation was estimated as a representative of anchorage-independent growth ability. Three independent experiments were performed using three different clones of each derivative, and a representative one is shown in Fig. 5 (A and B). Stable expression of Akt and SGK constructs was confirmed by immunoblotting with anti-Myc tag, anti-Akt, and anti-SGK antibodies (Fig. 5B). Similar to observations in cells transiently overexpressing Akt or SGK due to adenoviral transfer, stable overexpression of myr-Akt, D-SGK, and myr-SGK significantly increased the phosphorylation level of GSK3, whereas that of other constructs did not. These cells were subjected to soft agar assay to evaluate their transforming activity. As shown in Fig. 5B (middle panel), myr-Akt-expressing cells formed many macroscopic colonies within 14 days after being seeded. In contrast, although d-SGK- and myr-SGK-expressing cells showed phosphorylation of GSK3, they apparently could not make colonies (Fig. 5B, upper and lower panels). The colonies (counted from the three independent clones for each of the Akt and SGK constructs) are shown as bar graphs in Fig. 5C. Numerous serine/threonine kinases exist in the cell, and they play specific roles by inducing individual cellular functions. As to the molecular mechanisms underlying the various roles of each kinase protein, the substrate specificity of the kinase domain and subcellular distribution are considered to be major contributors. SGK and Akt are considered to be very similar kinase proteins, both of which belong to the AGC family. They are activated via phosphorylation by PDK1 and PDK2, located downstream from PI 3-kinase. However, the presence and absence of a PH domain in Akt and SGK, respectively, should result in different subcellular distributions of these two kinases. In the case of Akt, Akt translocates to the membrane fraction via binding of the PH domain with PI-3,4,5-P3 produced by PI 3-kinase, and phosphorylation of Thr306 and Ser473 of Akt by PDK1 and PDK2 takes place, thereby activating Akt kinase (30Burgering B.M. Coffer P.J. Nature. 1995; 376: 599-602Crossref PubMed Scopus (1880) Google Scholar, 31Alessi D.R. Andjelkovic M. Caudwell B. Cron P. Morrice N. Cohen P. Hemmings B.A. EMBO J. 1996; 15: 6541-6551Crossref PubMed Scopus (2517) Google Scholar, 32Alessi D.R. James S.R. Downes C.P. Holmes A.B. Gaffney P.R. Reese C.B. Cohen P. Curr. Biol. 1997; 7: 261-269Abstract Full Text Full Text PDF PubMed Google Scholar). myr-Akt is located at the plasma membrane without stimulation and is constitutively activated (10Kohn A.D. Summers S.A. Birnbaum M.J. Roth R.A. J. Biol. Chem. 1996; 271: 31372-31378Abstract Full Text Full Text PDF PubMed Scopus (1093) Google Scholar, 33Andjelkovic M. Alessi D.R. Meier R. Fernandez A. Lamb N.J. Frech M. Cron P. Cohen P. Lucocq J.M. Hemmings B.A. J. Biol. Chem. 1997; 272: 31515-31524Abstract Full Text Full Text PDF PubMed Scopus (900) Google Scholar). Then, Akt phosphorylates several substrates that transmit signals (6Vanhaesebroeck B. Alessi D.R. Biochem. J. 2000; 346: 561-576Crossref PubMed Scopus (1399) Google Scholar). In this study, to investigate the different roles of Akt and SGK, active as well as membrane-targeted active mutants of these kinases were overexpressed. Previous studies have established the functions induced by and the roles of activated Akt, and all or most of these cellular actions, for which Akt is reportedly responsible, are indeed induced by overexpression of myr-Akt (33Andjelkovic M. Alessi D.R. Meier R. Fernandez A. Lamb N.J. Frech M. Cron P. Cohen P. Lucocq J.M. Hemmings B.A. J. Biol. Chem. 1997; 272: 31515-31524Abstract Full Text Full Text PDF PubMed Scopus (900) Google Scholar, 34Ozes O.N. Mayo L.D. Gustin J.A. Pfeffer S.R. Pfeffer L.M. Donner D.B. Nature. 1999; 401: 82-85Crossref PubMed Scopus (1898) Google Scholar, 35Romashkova J.A. Makarov S.S. Nature. 1999; 401: 86-90Crossref PubMed Scopus (1667) Google Scholar, 36Meier R. Alessi D.R. Cron P. Andjelkovic M. Hemmings B.A. J. Biol. Chem. 1997; 272: 30491-30497Abstract Full Text Full Text PDF PubMed Scopus (327) Google Scholar, 37Welch H. Eguinoa A. Stephens L.R. Hawkins P.T. J. Biol. Chem. 1998; 273: 11248-11256Abstract Full Text Full Text PDF PubMed Scopus (86) Google Scholar). Thus, although this study was carried out employing an overexpression system, the cellular actions described herein are considered to be physiological functions induced by Akt. For example, it is well established that Akt plays a major role in glucose metabolism, including increased glycogen synthase and GLUT4 translocation to the plasma membrane, functions that can be induced by overexpressing myr-Akt (10Kohn A.D. Summers S.A. Birnbaum M.J. Roth R.A. J. Biol. Chem. 1996; 271: 31372-31378Abstract Full Text Full Text PDF PubMed Scopus (1093) Google Scholar, 11Hajduch E. Alessi D.R. Hemmings B.A. Hundal H.S. Diabetes. 1998; 47: 1006-1013Crossref PubMed Scopus (296) Google Scholar). Indeed, translocation of Akt to the plasma membrane is suggested to be important for glucose transport. In addition, the oncogenic activity of Akt is also well known since v-Akt has been identified as an oncogenic protein, and this promotion of cell growth activity is similarly observed upon overexpression of myr-Akt (38Aoki M. Batista O. Bellacosa A. Tsichlis P. Vogt P.K. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 14950-14955Crossref PubMed Scopus (258) Google Scholar, 39Sun M. Wang G. Paciga J.E. Feldman R.I. Yuan Z.Q. Ma X.L. Shelley S.A. Jove R. Tsichlis P.N. Nicosia S.V. Cheng J.Q. Am. J. Pathol. 2001; 159: 431-437Abstract Full Text Full Text PDF PubMed Scopus (405) Google Scholar). We obtained two important conclusions from this comparative study of SGK and Akt mutants. The first is that SGK can mediate GSK3 phosphorylation and the resultant glycogen synthesis, but not other cellular functions induced by Akt such as increased glucose transport, inhibition of apoptosis, and oncogenic transformation. Thus, it is possible that increased expression of SGK inhibits the phosphorylation of Akt and the resultant cellular functions such as increased glucose transport, inhibition of apoptosis, and cell proliferation because these two kinases are similarly phosphorylated by PDK1 and PDK2. Conversely, an increase in SGK may contribute to increased glycogen synthesis by increasing the phosphorylation of GSK3. In addition, a previous report showed that overexpression of the myristoylated and PH domain-deleted form of Akt induces an increase in glucose transport activity in 3T3-L1 adipocytes (10Kohn A.D. Summers S.A. Birnbaum M.J. Roth R.A. J. Biol. Chem. 1996; 271: 31372-31378Abstract Full Text Full Text PDF PubMed Scopus (1093) Google Scholar). Therefore, these different roles of the two kinases are apparently not attributable to membrane-targeting ability or an unidentified mechanism of signal transduction from the PH domain, caused by the presence or absence of the PH domain, because myristoylated and PH domain-deleted Akt, but not myr-SGK, enhanced glucose transport, inhibition of apoptosis, and cell proliferation. GSK3 is well established as a regulator of glycogen metabolism (22Cross D.A. Alessi D.R. Cohen P. Andjelkovich M. Hemmings B.A. Nature. 1995; 378: 785-789Crossref PubMed Scopus (4376) Google Scholar, 40Frame S. Cohen P. Biochem. J. 2001; 359: 1-16Crossref PubMed Scopus (1280) Google Scholar, 41Cohen P. Frame S. Nat. Rev. Mol. Cell. Biol. 2001; 2: 769-776Crossref PubMed Scopus (1302) Google Scholar, 42Brady M.J. Kartha P.M. Aysola A.A. Saltiel A.R. J. Biol. Chem. 1999; 274: 27497-27504Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar). Many proteins in this family are related to protein synthesis. Wnt signaling and transcription factors have been reported to be substrates of GSK3, and Somervaille et al. (43Somervaille T.C. Linch D.C. Khwaja A. Blood. 2001; 98: 1374-1381Crossref PubMed Scopus (106) Google Scholar) described GSK3 and Bax as being involved in the suppression of apoptosis induced by growth factor withdrawal. However, our results suggest that GSK3 is very likely to be independent of Akt-induced cellular actions such as increased glucose transport, inhibition of apoptosis, and cell proliferation. As discussed above, the different cellular functions induced by Akt and SGK cannot be attributed to the difference in membrane targeting through the PH domain. Although it has been reported that substrate specificities for synthetic peptides differ minimally between Akt and SGK based on an in vitro experiment using glutathione S-transferase fusion proteins and synthetic peptides (16Casamayor A. Torrance P.D. Kobayashi T. Thorner J. Alessi D.R. Curr. Biol. 1999; 9: 186-197Abstract Full Text Full Text PDF PubMed Scopus (204) Google Scholar), we speculate that considerable differences in terms of in vivo substrate specificity exist between these kinases, which account for the apparent differences in the roles of Akt and SGK. In other words, there may be some unidentified proteins phosphorylated by Akt, but not by SGK, that play key roles in glucose transport and anti-apoptotic effects, whereas GSK3 plays only minor roles in these functions. In conclusion, we have demonstrated for the first time an important difference between Akt and SGK and that this difference is not due to membrane localization, but rather possibly to the difference in their kinase activities. The identification of substrates selectively phosphorylated by Akt, but not by SGK, may provide clues to clarifying the pathway leading from Akt activation to the aforementioned cellular activities." @default.
• W2160361307 created "2016-06-24" @default.
• W2160361307 creator A5007583907 @default.
• W2160361307 creator A5011380065 @default.
• W2160361307 creator A5023318918 @default.
• W2160361307 creator A5033739246 @default.
• W2160361307 creator A5038413661 @default.
• W2160361307 creator A5058711798 @default.
• W2160361307 creator A5058806049 @default.
• W2160361307 creator A5061833051 @default.
• W2160361307 creator A5062239244 @default.
• W2160361307 creator A5065686098 @default.
• W2160361307 creator A5071430885 @default.
• W2160361307 creator A5078941067 @default.
• W2160361307 creator A5085709435 @default.
• W2160361307 creator A5087983151 @default.
• W2160361307 creator A5088372604 @default.
• W2160361307 creator A5089026261 @default.
• W2160361307 date "2003-07-01" @default.
• W2160361307 modified "2023-10-14" @default.
• W2160361307 title "Differing Roles of Akt and Serum- and Glucocorticoid-regulated Kinase in Glucose Metabolism, DNA Synthesis, and Oncogenic Activity" @default.
• W2160361307 cites W1617532721 @default.
• W2160361307 cites W1639582946 @default.
• W2160361307 cites W1726025741 @default.
• W2160361307 cites W1972307668 @default.
• W2160361307 cites W1974186712 @default.
• W2160361307 cites W1977518774 @default.
• W2160361307 cites W1982479809 @default.
• W2160361307 cites W1982915364 @default.
• W2160361307 cites W1989294105 @default.
• W2160361307 cites W1991468122 @default.
• W2160361307 cites W1993216157 @default.
• W2160361307 cites W1993835711 @default.
• W2160361307 cites W2004710215 @default.
• W2160361307 cites W2008987764 @default.
• W2160361307 cites W2010337187 @default.
• W2160361307 cites W2012079492 @default.
• W2160361307 cites W2019561720 @default.
• W2160361307 cites W2028220020 @default.
• W2160361307 cites W2028839582 @default.
• W2160361307 cites W2031469256 @default.
• W2160361307 cites W2034397029 @default.
• W2160361307 cites W2039193709 @default.
• W2160361307 cites W2044868069 @default.
• W2160361307 cites W2048171645 @default.
• W2160361307 cites W2053073281 @default.
• W2160361307 cites W2058138221 @default.
• W2160361307 cites W2062934426 @default.
• W2160361307 cites W2064242629 @default.
• W2160361307 cites W2070732456 @default.
• W2160361307 cites W2077478539 @default.
• W2160361307 cites W2094734472 @default.
• W2160361307 cites W2094918956 @default.
• W2160361307 cites W2096441744 @default.
• W2160361307 cites W2101400542 @default.
• W2160361307 cites W2107446346 @default.
• W2160361307 cites W2112620000 @default.
• W2160361307 cites W2119911216 @default.
• W2160361307 cites W2128710251 @default.
• W2160361307 cites W2146157811 @default.
• W2160361307 cites W2149489509 @default.
• W2160361307 cites W2162193671 @default.
• W2160361307 cites W2169494292 @default.
• W2160361307 cites W2388163742 @default.
• W2160361307 cites W2407196586 @default.
• W2160361307 cites W4245705226 @default.
• W2160361307 cites W4256264762 @default.
• W2160361307 doi "https://doi.org/10.1074/jbc.m301127200" @default.
• W2160361307 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12734207" @default.
• W2160361307 hasPublicationYear "2003" @default.
• W2160361307 type Work @default.
• W2160361307 sameAs 2160361307 @default.
• W2160361307 citedByCount "110" @default.
• W2160361307 countsByYear W21603613072012 @default.
• W2160361307 countsByYear W21603613072013 @default.
• W2160361307 countsByYear W21603613072014 @default.
• W2160361307 countsByYear W21603613072015 @default.
• W2160361307 countsByYear W21603613072016 @default.
• W2160361307 countsByYear W21603613072017 @default.
• W2160361307 countsByYear W21603613072018 @default.
• W2160361307 countsByYear W21603613072020 @default.
• W2160361307 countsByYear W21603613072021 @default.
• W2160361307 countsByYear W21603613072022 @default.
• W2160361307 crossrefType "journal-article" @default.
• W2160361307 hasAuthorship W2160361307A5007583907 @default.
• W2160361307 hasAuthorship W2160361307A5011380065 @default.
• W2160361307 hasAuthorship W2160361307A5023318918 @default.
• W2160361307 hasAuthorship W2160361307A5033739246 @default.
• W2160361307 hasAuthorship W2160361307A5038413661 @default.
• W2160361307 hasAuthorship W2160361307A5058711798 @default.
• W2160361307 hasAuthorship W2160361307A5058806049 @default.
• W2160361307 hasAuthorship W2160361307A5061833051 @default.
• W2160361307 hasAuthorship W2160361307A5062239244 @default.
• W2160361307 hasAuthorship W2160361307A5065686098 @default.
• W2160361307 hasAuthorship W2160361307A5071430885 @default.
• W2160361307 hasAuthorship W2160361307A5078941067 @default.
• W2160361307 hasAuthorship W2160361307A5085709435 @default.
• W2160361307 hasAuthorship W2160361307A5087983151 @default.

• next